MYCL | Mycotech Lab

What MYCL | Mycotech Lab does

MYCL (Mycotech Lab), founded in 2015 in Bandung, Indonesia, is a bio-material company that cultivates mushroom mycelium and algae to convert agricultural and marine waste into high-performance materials. Its core technology produces Mylea™, a mycelium-based leather alternative grown in controlled environments with customizable surface texture, and Mylea™ Sea, an algae-based biopolymer derived from Indonesian red seaweed (carrageenan). The company has extended this platform into structural and architectural materials, including MYCL Composite, MycoBlox modular units, BIBO Panels, and KINOLI® (a 100% mycelium leather produced in Nagano, Japan), with documented technical properties such as 1.55-ton compressive load capacity at 1.6 kg unit weight, fire resistance, and acoustic insulation.

MYCL monetizes through three revenue streams: direct-to-consumer e-commerce of finished accessories and furniture (store.mycl.bio), B2B material licensing and co-design collaborations with fashion, footwear, lighting, audio, and timepiece brands (JR East, Hijack, Doublet, Exsport, Pala, Nouv, Iter), and government- or accelerator-backed development programs (GROW Impact Accelerator, Sintesa 2025). Its go-to-market relies heavily on high-prestige design venues (Paris Fashion Week, Seoul Biennale, Venice Biennale) and academic partnerships (Bunka Fashion College, UPH Architecture Department) to seed brand collaborations and enterprise adoption.

As of 2025, MYCL operates production facilities in Bandung (HQ) and Nagano Prefecture, Japan, via its MYCL Japan subsidiary, with stated plans for a Singapore research facility. The company holds 11–50 employees, B Corp certification (B Impact Score 81.5), the Solar Impulse Efficient Solution label, a 2023 Good Design Indonesia award, and a 2024 Earthshot Prize finalist nomination, and has raised approximately US$1.4 million in disclosed equity and grant funding since 2018.

Name

MYCL | Mycotech Lab

Legal name

Mycotech Lab

Website

https://mycl.bio

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

MYCL (Mycotech Lab) is an Indonesian biomaterials company founded in 2015 that cultivates mushroom mycelium and algae to produce mycelium leather (Mylea™), algae biopolymer (Mylea™ Sea), and carbon-sequestering building materials, supplying sustainable fashion, footwear, and architecture brands and operating a DTC e-commerce store.

Ownership category

akta.pro rank

Product category

Bio-based Sustainable Materials Manufacturing

NAICS

Plastics and Rubber Products Manufacturing (326)

SIC

Plastics Products, Nec (3089)

akta.pro primary industry

Vegan/Alternative Material Goods Manufacturing (PU/Plant-based/Mycelium) (IMAOAHAH)

akta.pro secondary industries

Sustainable Protective & Cushioning Materials (Paper Cushions, Bio-Foams, Mycelium) (IMALAMAH), Biodegradable Packaging Materials (films, trays, foams) (IMAEAOAB)

Keywords

• Bio-based materials
• Mycelium composites
• Sustainable leather alternatives
• Agricultural waste upcycling
• Algae biopolymers

Headquarters

HQ city

Bandung

HQ country

Indonesia

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Direct E-commerce Sales: Consumer sales of finished products through own online store (store.mycl.bio). Products include wallets, passport cases, phone bags, travel bags, pouches, lanyards, furniture items (Shroom Stool), and modular building systems (B-Blocks).
2. B2B Material Licensing: Supply of proprietary mycelium and algae-based materials to fashion brands, footwear manufacturers, interior designers, and architectural firms for incorporation into their products.
3. Custom Design Collaborations: Co-development partnerships with brands for custom product lines using Mylea™ and Mylea™ Sea materials, as seen with collaborations like Hijack Sandals, Doublet, and others.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

MYCL is an Indonesian bio-material company that develops and manufactures sustainable materials by cultivating mushroom mycelium and processing algae to convert agricultural waste (including sugarcane bagasse and sawdust) into leather alternatives, composite boards, and finished consumer goods. The company produces mycelium-based leather substitutes, algae-based biopolymers, composite panels, and downstream products such as wallets, bags, and furniture.

Product overview

MYCL (Mycotech Lab) is an innovative bio-material company that develops high-performance, carbon-sequestering materials from mushroom mycelium and algae. The company operates a multi-brand portfolio centered on four core materials: Mylea™ (mycelium-based leather alternative), Mylea™ Sea (algae-based biopolymer), MYCL Composite (structural bio-composite for architecture), and KINOLI® (100% mycelium leather produced in Japan). These core materials feed into a diverse range of consumer products including wallets, lanyards, passport cases, bags, and furniture items like the Shrūm Stool and Nessim Mycoplanter, as well as architectural products such as MycoBlox and B-Blocks modular building systems. The company also collaborates with fashion brands on co-branded products like the Mimic Mylea™ sandals with Hijack.

Differentiator

Problem solved

Functional benefit

Brands

• Mylea: Premium bio-leather alternative made from mushroom mycelium; leather-like material with customizable surface texture, cruelty-free and compostable
• Mylea Sea
• KINOLI
• MYCL Composite
• MycoBlox
• BIBO Panels
• Biobo

Products and services

• Mylea Mycelium leather alternative material sold to fashion, footwear, and accessory brands as a sustainable substitute for animal leather.
• Mylea Sea Algae-derived biopolymer material offered as an additional sustainable bio-based input for product designers and manufacturers.
• MYCL Composite Composite board material produced from mycelium bound with agricultural waste, used by manufacturers as a sustainable panel input.
• MycoBlox Mycelium-grown block products supplied to industrial customers for use in design, construction, and packaging applications.
• BioBo Bio-board panel product offered as a sustainable alternative to conventional engineered boards for furniture and interior applications.
• B-Blocks Mycelium-based building block products developed for construction and design uses.
• KINOLI Finished consumer goods product line sold through MYCL's online channels, featuring items made from the company's mycelium and bio-composite materials.
• Mycotech consumer goods Direct-to-consumer product line including wallets, bags, and furniture manufactured from MYCL's mycelium and composite materials, sold via the company's online store.

Quantifiable outcome

• 16.8% lower emissions compared to bovine leather
• +4 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Eight partnerships are on record, tiered core, strategic and supporting.

• JR East (East Japan Railway Company)coreStrategic or Co-development Partner · 1 January 2025Strategic partnership for commercial adoption of KINOLI® mycelium leather. JR East has adopted KINOLI® (100% mycelium leather produced in Nagano) for official ID card tags at Takanawa Gateway City office, demonstrating commercial readiness of MYCL's mycelium technology.
• Anomalia (India)coreStrategic or Co-development Partner · 1 January 2025Collaboration for architecture projects including MycoMuseum at Venice Biennale and mycelium facades at Seoul Biennale. MYCL provides material research and production; Anomalia provides design and research. Represents Global South innovation on world stage.
• Bunka Fashion CollegestrategicStrategic or Co-development Partner · 1 January 2025Ongoing research collaboration ensuring Mylea™ and Mylea™ Sea materials are integrated into Japan fashion education, developing next generation of sustainable Japanese fashion designers.
• Indonesian Embassy Tokyo (KBRI Tokyo)supportingGTM or Marketing Partner · 1 January 2025Strategic support for Discover Indonesia pop-up store event at Hibiya Okuroji, official showcase of MYCL's Earth and Ocean portfolio to Japanese market.
• Indonesian Ministry of Creative Economy (Ekraf) & PlayostrategicGTM or Marketing Partner · 1 January 2025Sintesa 2025 acceleration program supporting material scaling and local collaboration. Five designers paired with brands to create products from Mylea and Mylea Sea materials.
• VIBRAMsupportingTechnology or Integration · 1 January 2023VIBRAM Ripple outsole technology featured in Mimic Mylea sandal collaboration with Hijack Sandals, providing extra grip and comfort.
• UPH (Universitas Pelita Harapan) Architecture DepartmentstrategicStrategic or Co-development PartnerCollaboration for B-Blocks modular building system development. Revolutionary bio-fabricated modular system using carbon-negative mycelium with unique interlocking geometry.
• Nusantara JapansupportingGTM or Marketing PartnerCo-curated Discover Indonesia pop-up store event introducing MYCL materials to Japanese audience at Hibiya Okuroji historic venue.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Ecovative Design: US mycelium technology company with mycelium packaging (EcoFoam) and mycelium textile materials (Forager). Comparable on mycelium-growth technology, multi-product mycelium portfolio, and supply to consumer/industrial end markets.
• Bolt Threads: US biotech producing Mylo™ mycelium leather and other bio-fabricated materials for apparel and footwear. Comparable on bio-material R&D, B2B licensing to fashion brands, and cross-vertical material platform approach.
• Modern Meadow: US biotech developing biofabricated and bio-based leather alternatives (formerly Bioleather/Spiber-adjacent tech). Comparable on R&D-driven biomaterial approach to leather replacement, B2B materials model for fashion customers.
• Mogu: Italian mycelium-materials company focused on interior design and architectural surfaces. Directly comparable on use of mycelium composites for interiors and architecture, B2B sales to designers, and sustainability positioning.
• MycoWorks: US-based pioneer of mycelium-based leather (Reishi™) used by leading luxury fashion houses. Most directly comparable to MYCL on mycelium material technology, target fashion/luxury customers, and vertically-integrated material-to-product value chain - though at materially larger funding scale.

Emerging players

• Ananas Anam (Piñatex): UK-based producer of Piñatex, a pineapple-leaf-fiber leather alternative. Comparable as a plant-based leather alternative competing for the same fashion and accessory brand customers that MYCL targets with Mylea and KINOLI.
• Vegea: Italian grape-skin-based vegan leather producer serving fashion and upholstery end markets. Comparable on agricultural-waste-to-leather-alternative positioning, European presence, and B2B materials licensing model.
• Desserto: Mexican cactus-leather alternative supplier serving fashion, footwear, and automotive interiors. Comparable as a bio-based alternative-leather brand licensing material to apparel and accessories customers.
• Reishi / Polish mycelium leather brands: European early-stage mycelium-leather producers entering the same fashion/accessories market as MYCL. Comparable on scale, technology stack, and target customers.

Broad incumbents

• Spiber: Japan-based Brewed Protein™ materials company (fermented protein polymers for apparel and automotive). Comparable as a bio-material platform supplying premium apparel brands in Asia, particularly relevant given MYCL's Japan expansion.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/mycl.bio

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds5 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MYCL | Mycotech Lab